With the FDA approval of Zepbound (tirzepatide) for obstructive sleep apnea, GLP-1 receptor agonists harbor potential beyond weight and diabetes management.

Black women face many challenges when receiving adequate sleep disorder treatment and diagnoses including neighborhood disadvantage, anti-Black ideologies, and the Superwoman schema.

Dr Umakanth Katwa and Dr Rafael Pelayo give clinical guidance on the accurate diagnosis and evidence-based treatment of pediatric insomnia.

The American Academy of Sleep Medicine published guidance regarding the treatment of restless leg syndrome and periodic limb movement disorder.

The ESRS and the EIN have released a guideline update for clinicians on the latest insights into insomnia and its treatment.